Print  |  Close

A Prospective Observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta® (pegfilgrastim) Onpro® kit or Other Physician Choice Options for Prophylaxis of Febrile Neutropenia

Active: Yes
Cancer Type: Breast Cancer
Lung Cancer
Non-Hodgkin Lymphoma
Prostate Cancer
Trial Phases: Protocol IDs: AMG 011 20170758 (primary)
Eligibility: , Male and Female Study Type: Other
Study Sponsor: Amgen
NCI Full Details:

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.